Phase Forward Customer GlaxoSmithKline Wins Prestigious Wall Street Journal Technology Innovation Award

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today congratulated its customer GSK on winning a 2008 Technology Innovation Award from The Wall Street Journal, taking top honors in the Healthcare IT category. The Journal received more than 700 entries for the awards.
MORE ON THIS TOPIC